This chemical is primarily used in the treatment of bone disorders, particularly those involving excessive bone resorption. It works by inhibiting osteoclast activity, which helps in reducing bone loss and improving bone density. It is often employed in managing conditions like osteoporosis, Paget's disease, and bone metastases associated with certain cancers. Additionally, it can be used in veterinary medicine for similar purposes in animals. Its ability to bind to hydroxyapatite in bones makes it effective in targeting areas of high bone turnover, ensuring localized therapeutic action.